SOURCE: The Alliance for Regenerative Medicine

The Alliance for Regenerative Medicine

September 29, 2011 09:00 ET

The Alliance for Regenerative Medicine Reveals Initial Group of Presenting Companies at the 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum

First and Only Partnering Event Focused Exclusively on Facilitating Access to Capital and Business Development in the Regenerative Medicine Field

WASHINGTON, DC--(Marketwire - Sep 29, 2011) - The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced that the initial group of presenting companies has been selected for the inaugural Investor and Partnering Forum taking place at the 2011 Stem Cell Meeting on the Mesa. In its 6th year, this well-known Symposium, which draws over 600 attendees from the business, academic and patient advocacy communities, has now gone global with the inclusion of this first-ever investor and partnering event designed specifically to showcase the leading companies and investigators in regenerative medicine.

This event was developed by the Sanford Consortium, CIRM and ARM to specifically facilitate translational research, PI engagement in the business community and provide the opportunity for hundreds of business, academic research and investor participants to connect for one-on-one meetings and strategic partnering. The Investor and Partnering Forum is expected to draw hundreds of business, academic research and investor attendees. The meeting will take place on November 30 and December 1, 2011 at the Sanford Consortium for Regenerative Medicine in La Jolla, California.

The following companies have been selected to present at The Investor and Partnering Forum. Additional participants will be announced at a later date:

2011 Presenting Companies and Institutions:

Advanced BioHealing, Advanced Cell Technology, Aldagen, AlloSource, American Stem Cell, Athersys, bluebird bio, Cellerant Therapeutics, City of Hope, Cytori Therapeutics, Juventas Therapeutics, Kiadis, Medipost, Medpace, MolMed S.p.A., Organogenesis, Organovo, Pervasis Therapeutics, Progenitor Cell Therapy, Proxy Biomedical, ReNeuron, Sangamo BioSciences, Sistemic, StemCells, Inc., Stanford University, Tissue Genesis, ViaCyte, UCLA, UCSD, Vet-Stem.

Other key companies participating in the conference include: Agilent, Johnson & Johnson, Invetech, Life Technologies, EMD Millipore, Pfizer, Roche, Roth Capital, Shire.

To learn more and to register for the 2011 Stem Cell Meeting on the Mesa Symposium and Investor and Partnering Forum, please visit www.stemcellmeetingonthemesa.com. Registration is complimentary for credentialed members of the media.

The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based non-profit organization that promotes legislative, regulatory, reimbursement, and financing initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, and provides services to support the growth of its member companies and organizations. Prior to the formation of ARM, there was no advocacy organization operating in Washington, DC to specifically represent the interests of regenerative medicine companies, research institutions, investors, and patient groups supporting more rapid adoption of technologies in our field. To learn more about ARM or to become a member, visit www.alliancerm.org.

Contact Information

  • Media Contact:
    Michelle Linn
    Linnden Communications
    Phone: 508-362-3087